CTRI/2014/10/005085招募中1/2 期
A STUDY ON VYANABALA VRIDDHI (ESSENTIAL HYPERTENSION) AND ITS MANAGEMENT WITH JATAMANSYADI VATI
Institute for Post Graduate Teaching And Research in Ayurveda1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2014年7月4日最近更新:
适应症
试验速览
- 阶段
- 1/2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- control of hypertension
研究概览
简要总结
This is a randomized control clinical trial at I P G T and R A, Gujarat Ayurved University, Jamnagar in Department of Kayachikitsa OPD. Dealing with treatment of Vyanabala Vriddhi (essential hypertension). In present study Jatamansyadi Vati which contain Jatamansi, Ashwagandha, Arjuna, Gokshura and Brahmi in equal parts will be given 1 gm BD for 28 days as interventional group. In control group Metoprolol will be given 25 mg or 50 mg OD for 28 days.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 25.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients above 25 years and below 65 years of age will be selected for the study Patients with systolic blood pressure above 140 mm of Hg and below 180 mm of Hg will be taken for the study Patients with diastolic blood pressure above 90 mm of Hg and below 110 mm of Hg will be taken for the study Patients presenting with the classical symptoms of Hypertension will be taken for the study.
排除标准
- •Patients below 25 years and above 65 years of age will be excluded from the study Patients with systolic blood pressure below 140 mm of Hg and above 180 mm of Hg will be excluded from the study Patients with diastolic blood pressure below 90 mm of Hg and above 110 mm of Hg will be excluded from the study Patients having major illness like severe D.M., tuberculosis, major endocrine disorders, malignancies, HIV, renal failure will be excluded from the study Patients having accelerated and malignant hypertension and history of cardiac compromise like angina, MI, CCF will also be excluded.
结局指标
主要结局
control of hypertension
时间窗: 28 days
次要结局
- improve quality of life(after 28 days)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A clinical trial to know the effect of Virulina® along with standard treatment in covid 19 positive patients.Coronavirus as the cause of diseases classified elsewhere,CTRI/2020/06/025556Natural Solutions30
尚未招募
不适用
Ayurvedic Management of Pulmonary Eosinophilia- A Clinical StudyPulmonary eosinophilia, not elsewhere classified. Ayurveda Condition: EA-3.2 MORBIDITY CODE FOR VATAJA KASA, (2) ICD-10 Condition: J82||Pulmonary eosinophilia, not elsewhere classified, (3) ICD-10 Condition: J82||Pulmonary eosinophilia, not elsewhere classified,CTRI/2022/06/043421Dr Manjushri P30
尚未招募
2 期
A CLINICAL STUDY TO EVALUATE THE EFFICACY OF VRINDAMADHAVOKTA DASHAMULAADI KASHAYA IN THE MANAGEMENT OF GRIDHRASI WITH SPECIAL REFERENCE TO SCIATICALumbago with sciatica. Ayurveda Condition: GRUDHRASI,CTRI/2022/07/043799Snehal Navnath Jagtap33
招募中
不适用
Management of sciatica through enema and oral intake medicated oil.Other specified acquired deformities of musculoskeletal system,CTRI/2019/02/017470Rishikul campus40
尚未招募
3 期
Varma thadaval for kumbavatham with varmam vatha ennaiCTRI/2021/07/035149PS Devika